VIVOSIM
DEAD

Serial Number

86754342

Owner

ENMODES GMBH

Attorney

PRESTON SMIRMAN

Filing Date

Sep 11, 2015

Add to watchlist:

No watchlists yet
View on USPTO

VIVOSIM Trademark

Serial Number: 86754342 • Registration: 5148917

VIVOSIM is a trademark filed by ENMODES GMBH on September 11, 2015. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 45 (Legal & Security Services). The application is currently no longer active.

Owner Contact Info

ENMODES GMBH (2 trademarks)

PASSSTRASSE 106
AACHEN 52070 , DE

Entity Type: 16

Trademark Details

Filing Date

September 11, 2015

Registration Date

February 28, 2017

Published for Opposition

December 13, 2016

Cancellation Date

September 8, 2023

Goods & Services

Software for use in drug dosing in the field of drug development; Computer software for use in drug dosing in the field of drug development; Software for the prediction of drug efficiency; Computer software for the prediction of drug efficiency

Licensing of software; Licensing of software for the prediction of drug efficiency

Advisory services in the field of product development and quality improvement of software; Advisory services in the field of product development and quality improvement of software for the prediction of drug efficiency; Advisory services in the field of software design; Advisory services in the field of software design for software for the prediction of drug efficiency; Advisory services relating to software; Advisory services relating to software for the prediction of drug efficiency; Consulting and advisory services in the field of software; Consulting and advisory services in the field of software for the prediction of drug efficiency; Design of software; Design of computer software; Design of software for the prediction of drug efficiency; Design of computer software for the prediction of drug efficiency; Design services for software; Design services for computer software; Design services for software for the prediction of drug efficiency; Design services for computer software for the prediction of drug efficiency; Development of software; Development of computer software; Development of software for the prediction of drug efficiency; Development of computer software for the prediction of drug efficiency; Concept design and development of software for others; Concept design and development of computer software for others; Concept design and development of software for the prediction of drug efficiency for others; Concept design and development of computer software for the prediction of drug efficiency; Programming of software for others; Programming of software for the prediction of drug efficiency for others; Implementation of software; Implementation of software for the prediction of drug efficiency; Maintenance of software; Maintenance of software for the prediction of drug efficiency; Servicing of software, namely, updating and maintaining software for others; Servicing of software, namely, updating and maintaining software for others for the prediction of drug efficiency; Adaptation of software, namely, customization of software for others; Adaptation of software, namely, updating and maintaining software for others for the prediction of drug efficiency; Professional consultancy services relating to software creation; Professional consultancy services relating to software creation for software for the prediction of drug efficiency; Installation of software; Installation of software for the prediction of drug efficiency; Conception design and development of software for others; Conception design and development of software for others for the prediction of drug efficiency; Custom design of software packages; Custom design of software packages for the prediction of drug efficiency; Custom structuring, namely, design of software packages; Custom structuring, namely, design of software packages for the prediction of drug efficiency; Software engineering; Software engineering of software for the prediction of drug efficiency; Software creation; Software creation of software for the prediction of drug efficiency; Software customization; Software customization of software for the prediction of drug efficiency; Technical support in the field of software, namely, troubleshooting software problems; Technical support in the field of software for the prediction of drug efficiency, namely, troubleshooting software problems; Rental of software; Rental of computer software; Rental of software for the prediction of drug efficiency; Rental of computer software for the prediction of drug efficiency; Updating of software; Updating of software for the prediction of drug efficiency; Updating of computer software; Updating of computer software for the prediction of drug efficiency; Pharmaceutical drug development services, namely, prediction of drug efficiency and prediction of drug efficiency to optimize medical treatment

Filing History

CANCELLED SEC. 8 (6-YR)
Sep 8, 2023 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Feb 28, 2022 REM1
REGISTERED-PRINCIPAL REGISTER
Feb 28, 2017 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 13, 2016 NPUB
PUBLISHED FOR OPPOSITION
Dec 13, 2016 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 23, 2016 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Nov 4, 2016 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 26, 2016 CNSA
EXAMINER'S AMENDMENT ENTERED
Oct 26, 2016 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 26, 2016 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 26, 2016 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 26, 2016 CNEA
EXAMINER'S AMENDMENT ENTERED
Oct 26, 2016 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 26, 2016 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 26, 2016 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 26, 2016 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 5, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 5, 2016 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 21, 2016 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 12, 2016 GNRN
NON-FINAL ACTION E-MAILED
May 12, 2016 GNRT
NON-FINAL ACTION WRITTEN
May 12, 2016 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
May 10, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 10, 2016 CRFA
ASSIGNED TO LIE
May 6, 2016 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 25, 2016 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 28, 2015 GNRN
NON-FINAL ACTION E-MAILED
Dec 28, 2015 GNRT
NON-FINAL ACTION WRITTEN
Dec 28, 2015 CNRT
ASSIGNED TO EXAMINER
Dec 28, 2015 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 16, 2015 NWOS
NEW APPLICATION ENTERED
Sep 15, 2015 NWAP